Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.5966/sctm.2014-0294 | Concise Review: Process Development Considerations for Cell Therapy |
| https://doi.org/10.1016/j.jcyt.2016.03.295 | Off the shelf cellular therapeutics: Factors to consider during cryopreservation and storage of human cells for clinical use |
| https://doi.org/10.1038/nbt.2973 | Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells |
| https://doi.org/10.1517/14712598.2012.631909 | International seminar on the red blood cells as vehicles for drugs |
| https://doi.org/10.1016/j.jcyt.2014.10.012 | Tracheal bioengineering: the next steps. Proceeds of an International Society of Cell Therapy Pulmonary Cellular Therapy Signature Series Workshop, Paris, France, April 22, 2014 |
| https://doi.org/10.1016/j.jcyt.2017.10.002 | Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions |
| https://doi.org/10.1016/j.jcyt.2023.03.002 | International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products |
| https://doi.org/10.1016/j.jcyt.2020.11.005 | Cell and gene therapy: a snapshot of investor perspectives |
| https://doi.org/10.1016/j.jcyt.2021.09.009 | ISCT survey on hospital practices to support externally manufactured investigational cell-gene therapy products |
| https://doi.org/10.1016/j.jcyt.2024.05.007 | International Society for Cell and Gene Therapy Clinical Translation Committee recommendations on mesenchymal stromal cells in graft-versus-host disease: easy manufacturing is faced with standardizing and commercialization challenges |
| https://doi.org/10.1016/j.jcyt.2022.07.014 | Particulates are everywhere, but are they harmful in cell and gene therapies? |
| https://doi.org/10.1016/j.jemep.2021.100684 | Ethical issues in genetics and infectious diseases research: An interdisciplinary expert review |
| https://doi.org/10.1016/j.jcyt.2021.12.012 | Impact considerations of post-production processes on cell and gene drug products |
| https://doi.org/10.1016/j.jcyt.2025.01.016 | International Society for Cell & Gene Therapy Expanded Access Working Group position paper: key considerations to support equitable and ethical expanded access to investigational cell- and gene-based interventions |
| https://doi.org/10.1016/j.jcyt.2025.03.504 | Pursuing cell therapy approvals in APAC: your guide to navigating regulations in Japan, South Korea, and Singapore |
| https://doi.org/10.1016/j.jcyt.2025.06.010 | Advancing gene-editing platforms to improve the viability of rare-disease therapeutics: key insights from a 2024 Scientific Exchange hosted by ARM, ISCT, and Danaher |
| https://doi.org/10.1038/s41587-025-02744-3 | Platform solutions for commercial challenges to expanding patient access and making gene editing sustainable |
| https://doi.org/10.1016/j.jcyt.2019.02.003 | Advancing cellular therapies towards standard of care: a focus on testing of cellular therapy products |
| https://doi.org/10.1016/j.jcyt.2025.04.060 | Shaping the future of cell and gene therapy workforce development: training of cell therapy processing personnel - perspectives from the International Society for Cell & Gene Therapy Lab Practices Committee |
| https://doi.org/10.1016/j.jcyt.2019.03.005 | Current state of Health Canada regulation for cellular and gene therapy products: potential cures on the horizon |
| https://doi.org/10.1016/j.jcyt.2016.10.017 | The path to successful commercialization of cell and gene therapies: empowering patient advocates |
| https://doi.org/10.3109/14653249.2012.706709 | Managing particulates in cellular therapy |
| https://doi.org/10.1016/j.jcyt.2020.06.011 | Transitioning from development to commercial: risk-based guidance for critical materials management in cell therapies |
| https://doi.org/10.1016/j.jcyt.2023.05.008 | Mesenchymal stromal cells extracellular vesicles; unlocking the potential |
| https://doi.org/10.1089/bio.2020.29072.cys | ISBER in the Time of COVID |
| https://doi.org/10.1007/b102110_2 | The Regulatory Situation for Academic Cell Therapy Facilities in Europe |
| https://doi.org/10.1158/1538-7445.am2014-5319 | Abstract 5319: The role of ISBER (The International Society for Biological and Environmental Repositories) in cancer research |
| https://doi.org/10.2217/rme.10.102 | Institutional Profile: The International Society for Cellular Therapy: Evolving to Meet the Demands of the Regenerative Medicine Industry |
| https://doi.org/10.1016/b978-0-12-803115-5.06001-0 | Foreword |